Detalles de la búsqueda
1.
Signatures of GVHD and relapse after posttransplant cyclophosphamide revealed by immune profiling and machine learning.
Blood;
139(4): 608-623, 2022 01 27.
Artículo
en Inglés
| MEDLINE | ID: mdl-34657151
2.
Haploidentical donor hematopoietic cell transplantation for myelodysplastic/myeloproliferative overlap neoplasms: results from a North American collaboration.
Haematologica;
108(12): 3321-3332, 2023 Dec 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-37408464
3.
The Impact of Clinical and Pathological Features on Intraductal Papillary Mucinous Neoplasm Recurrence After Surgical Resection: Long-Term Follow-Up Analysis.
Ann Surg;
275(6): 1165-1174, 2022 06 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-33214420
4.
Reversing the effects of androgen-deprivation therapy in men with metastatic castration-resistant prostate cancer.
BJU Int;
128(3): 366-373, 2021 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-33765326
5.
Thrombotic Microangiopathy after Post-Transplantation Cyclophosphamide-Based Graft-versus-Host Disease Prophylaxis.
Biol Blood Marrow Transplant;
26(12): 2306-2310, 2020 12.
Artículo
en Inglés
| MEDLINE | ID: mdl-32961372
6.
Allogeneic Haploidentical Blood or Marrow Transplantation with Post-Transplantation Cyclophosphamide in Chronic Lymphocytic Leukemia.
Biol Blood Marrow Transplant;
26(3): 502-508, 2020 03.
Artículo
en Inglés
| MEDLINE | ID: mdl-31730920
7.
Development of Grade II Acute Graft-versus-Host Disease Is Associated with Improved Survival after Myeloablative HLA-Matched Bone Marrow Transplantation using Single-Agent Post-Transplant Cyclophosphamide.
Biol Blood Marrow Transplant;
25(6): 1128-1135, 2019 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-30599208
8.
The prevalence of human papillomavirus in oropharyngeal cancer is increasing regardless of sex or race, and the influence of sex and race on survival is modified by human papillomavirus tumor status.
Cancer;
125(5): 761-769, 2019 03 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-30521092
9.
Grade II Acute Graft-versus-Host Disease and Higher Nucleated Cell Graft Dose Improve Progression-Free Survival after HLA-Haploidentical Transplant with Post-Transplant Cyclophosphamide.
Biol Blood Marrow Transplant;
24(2): 343-352, 2018 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-29055682
10.
Early Fever after Haploidentical Bone Marrow Transplantation Correlates with Class II HLA-Mismatching and Myeloablation but Not Outcomes.
Biol Blood Marrow Transplant;
24(10): 2056-2064, 2018 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-29909152
11.
Racial disparities in the rate of cardiotoxicity of HER2-targeted therapies among women with early breast cancer.
Cancer;
124(9): 1904-1911, 2018 05 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-29381193
12.
Outpatient CD19-directed CAR T-cell therapy is feasible in patients of all ages.
Br J Haematol;
203(4): 688-692, 2023 11.
Artículo
en Inglés
| MEDLINE | ID: mdl-37642134
13.
Accurate Nonendoscopic Detection of Esophageal Squamous Cell Carcinoma Using Methylated DNA Biomarkers.
Gastroenterology;
163(2): 507-509.e2, 2022 08.
Artículo
en Inglés
| MEDLINE | ID: mdl-35483446
14.
Allogeneic Blood or Marrow Transplantation with Post-Transplantation Cyclophosphamide as Graft-versus-Host Disease Prophylaxis in Multiple Myeloma.
Biol Blood Marrow Transplant;
23(11): 1903-1909, 2017 Nov.
Artículo
en Inglés
| MEDLINE | ID: mdl-28711728
15.
Risk-stratified outcomes of nonmyeloablative HLA-haploidentical BMT with high-dose posttransplantation cyclophosphamide.
Blood;
125(19): 3024-31, 2015 May 07.
Artículo
en Inglés
| MEDLINE | ID: mdl-25814532
16.
Comparable composite endpoints after HLA-matched and HLA-haploidentical transplantation with post-transplantation cyclophosphamide.
Haematologica;
102(2): 391-400, 2017 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-27846611
17.
Prognostic factors for clinical outcomes in patients with metastatic castration resistant prostate cancer treated with sequential novel androgen receptor-directed therapies.
Prostate;
76(5): 512-20, 2016 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-26689606
18.
Single-agent GVHD prophylaxis with posttransplantation cyclophosphamide after myeloablative, HLA-matched BMT for AML, ALL, and MDS.
Blood;
124(25): 3817-27, 2014 Dec 11.
Artículo
en Inglés
| MEDLINE | ID: mdl-25316679
19.
Isolated clonal cytogenetic abnormalities after high-dose therapy.
Biol Blood Marrow Transplant;
20(8): 1130-8, 2014 Aug.
Artículo
en Inglés
| MEDLINE | ID: mdl-24732780
20.
Differential expression of degradome components in cutaneous squamous cell carcinomas.
Mod Pathol;
27(7): 945-57, 2014 Jul.
Artículo
en Inglés
| MEDLINE | ID: mdl-24356192